Vistagen Therapeutics (VTGN) Return on Invested Capital [ROIC] (2017 - 2026)
Vistagen Therapeutics' Return on Invested Capital [ROIC] came in at -231.84% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 138.71 percentage points from -93.13% a year earlier and down 65.92 percentage points from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Return on Invested Capital [ROIC] (2017 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Return on Invested Capital [ROIC] was -136.08%, down 75.46 percentage points from FY2025.
- Return on Invested Capital [ROIC] carries a five-year change of -94.55 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Invested Capital [ROIC] was -60.62% in FY2025 (-8.40 pp), -52.22% in FY2024 (+101.92 pp), -154.14% in FY2023 (-93.16 pp) and -60.98% in FY2022 (-19.45 pp).
- The fiscal Q1 2027 figure represents the lowest quarterly Return on Invested Capital [ROIC] since fiscal Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - | -231.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -231.84% |
| Mar 31, 2026 | -165.92% |
| Jun 30, 2025 | -93.13% |
| Mar 31, 2024 | -27.80% |
| Dec 31, 2023 | -42.66% |
| Sep 30, 2023 | -165.37% |
| Jun 30, 2023 | -469.19% |
| Mar 31, 2023 | -356.19% |
| Dec 31, 2022 | -247.81% |
| Sep 30, 2022 | -166.60% |
| Jun 30, 2022 | -106.98% |
| Mar 31, 2021 | -19.30% |
| Dec 31, 2020 | -30.39% |
| Jun 30, 2019 | -586.41% |
| Mar 31, 2019 | -549.87% |
| Dec 31, 2018 | -783.77% |
| Sep 30, 2018 | -495.18% |
| Jun 30, 2018 | -309.77% |
| Mar 31, 2018 | -163.87% |
| Dec 31, 2017 | -289.93% |
API Access
Vistagen Therapeutics Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();